Clinical potential and putative risks of fertility preservation in children utilizing gonadal tissue or germline stem

Kirsi Jahnukainen1, Jens Ehmcke, Olle Söder

  • 1Department of Cell Biology and Physiology, Center for Research in Reproductive Physiology, University of Pittsburgh, School of Medicine, PA 15261, USA. Kirsi.Jahnukainen@kbh.ki.se

Pediatric Research
|March 22, 2006
PubMed

Insights

Advancements in generating fertile gametes from cryo-preserved gonadal tissue offer hope for preserving fertility in children undergoing cancer treatment or with other conditions requiring gonadotoxic therapies. This review explores experimental germ stem cell transplantation and its clinical implications for pediatric fertility preservation.

Area of Science:

  • Reproductive biology
  • Oncology
  • Pediatric medicine

Background:

  • Novel experimental strategies are emerging for generating fertile gametes from cryo-preserved ovarian and testicular tissue.
  • Fertility preservation is a critical concern for pediatric cancer patients and other groups at risk of gonadal damage.

Purpose of the Study:

  • To review the current state of experimental germ stem cell transplantation in higher primates, including humans.
  • To discuss the clinical risks and limitations of these procedures in children.
  • To explore future options for fertility preservation in pediatric populations.

Main Methods:

  • Review of current scientific literature on germ stem cell transplantation.
  • Analysis of experimental strategies in higher primates and humans.
  • Discussion of clinical risks and limitations in pediatric applications.

Main Results:

  • Experimental strategies for generating gametes from cryo-preserved gonadal tissue show significant progress.
  • Germ stem cell transplantation is an evolving field with potential applications in fertility preservation.
  • Clinical translation requires careful consideration of risks and limitations, particularly in children.

Conclusions:

  • Fertility preservation through experimental germ stem cell transplantation holds promise for children facing gonadotoxic treatments or other fertility-compromising conditions.
  • Further research and clinical evaluation are necessary to optimize safety and efficacy in pediatric patients.
  • This field offers potential future options for preserving reproductive potential in both boys and girls.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...